Our results demonstrated two main findings: (i) differential levels between groups (moderate increase in LTB, high in DS-TB, and extremely high in DR-TB) compared to HC and (ii) chemokines (CXCL10, CXCL9 and CXCL1) as the promising biomarker signature. This evidence concerns the gene CXCL10 and tuberculosis.